Search

Your search keyword '"Paku, Masakatsu"' showing total 8 results
Start Over Author "Paku, Masakatsu" Search Limiters Available in Library Collection
8 results on '"Paku, Masakatsu"'

4. Additional file 1 of Impact of the preoperative prognostic nutritional index as a predictor for postoperative complications after resection of locally recurrent rectal cancer

Author

Paku, Masakatsu, Uemura, Mamoru, Kitakaze, Masatoshi, Shiki Fujino, Ogino, Takayuki, Norikatsu Miyoshi, Takahashi, Hidekazu, Yamamoto, Hirofumi, Tsunekazu Mizushima, Doki, Yuichiro, and Eguchi, Hidetoshi

Abstract

Additional file 1: Supplemental Table 1. Primary tumor characteristics of the patients in this study.

Published
2021
Full Text
View/download PDF

5. Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer

Author

Kobayashi, Yuta, Uemura, Mamoru, Paku, Masakatsu, Kitakaze, Masatoshi, Tei, Mitsuyoshi, Kagawa, Yoshinori, Takeda, Mitsunobu, Sekido, Yuki, Hata, Tsuyoshi, Hamabe, Atsushi, Ogino, Takayuki, Miyoshi, Norikatsu, Doki, Yuichiro, Eguchi, Hidetoshi, Kobayashi, Yuta, Uemura, Mamoru, Paku, Masakatsu, Kitakaze, Masatoshi, Tei, Mitsuyoshi, Kagawa, Yoshinori, Takeda, Mitsunobu, Sekido, Yuki, Hata, Tsuyoshi, Hamabe, Atsushi, Ogino, Takayuki, Miyoshi, Norikatsu, Doki, Yuichiro, and Eguchi, Hidetoshi

Abstract

Kobayashi Y., Uemura M., Paku M., et al. Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer. Anticancer Research 44, 695 (2024); https://doi.org/10.21873/anticanres.16860 ., Background/Aim: Postoperative venous thromboembolism (VTE) is a well-recognized complication that leads to morbidity and mortality. Lateral lymph node dissection (LLND) for rectal cancer is thought to potentially increase the risk of VTE due to its technical complexity. However, the relationship between LLND and VTE remains inadequately understood. The aim of this study was to elucidate the impact of LLND on the incidence of postoperative VTE. Patients and Methods: This is a retrospective analysis of patients who underwent rectal cancer resection between 2010 and 2018 to identify the risk factors associated with postoperative VTE. Patients were divided into two groups: those who underwent surgery with LLND (LLND+ group) and those who underwent surgery without LLND (LLND– group). Results: A total of 543 patients were enrolled in this study, and 113 patients underwent surgery for rectal cancer with LLND. VTE developed in 8 patients (1.47%), with the incidence rates being 4.42% in the LLND+ group and 0.69% in the LLND–group, respectively (p=0.012). Three of 8 patients had developed severe postoperative complications, and the other two patients needed intraoperative repair of the iliac vein during LLND procedure. Multivariate analysis identified the incidence of postoperative complications and LLND as the independent risk factors of VTE. Conclusion: Patients undergoing rectal cancer surgery with LLND should be closely monitored for signs of VTE.

6. Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer

Author

Kobayashi, Yuta, Uemura, Mamoru, Paku, Masakatsu, Kitakaze, Masatoshi, Tei, Mitsuyoshi, Kagawa, Yoshinori, Takeda, Mitsunobu, Sekido, Yuki, Hata, Tsuyoshi, Hamabe, Atsushi, Ogino, Takayuki, Miyoshi, Norikatsu, Doki, Yuichiro, Eguchi, Hidetoshi, Kobayashi, Yuta, Uemura, Mamoru, Paku, Masakatsu, Kitakaze, Masatoshi, Tei, Mitsuyoshi, Kagawa, Yoshinori, Takeda, Mitsunobu, Sekido, Yuki, Hata, Tsuyoshi, Hamabe, Atsushi, Ogino, Takayuki, Miyoshi, Norikatsu, Doki, Yuichiro, and Eguchi, Hidetoshi

Abstract

Kobayashi Y., Uemura M., Paku M., et al. Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer. Anticancer Research 44, 695 (2024); https://doi.org/10.21873/anticanres.16860 ., Background/Aim: Postoperative venous thromboembolism (VTE) is a well-recognized complication that leads to morbidity and mortality. Lateral lymph node dissection (LLND) for rectal cancer is thought to potentially increase the risk of VTE due to its technical complexity. However, the relationship between LLND and VTE remains inadequately understood. The aim of this study was to elucidate the impact of LLND on the incidence of postoperative VTE. Patients and Methods: This is a retrospective analysis of patients who underwent rectal cancer resection between 2010 and 2018 to identify the risk factors associated with postoperative VTE. Patients were divided into two groups: those who underwent surgery with LLND (LLND+ group) and those who underwent surgery without LLND (LLND– group). Results: A total of 543 patients were enrolled in this study, and 113 patients underwent surgery for rectal cancer with LLND. VTE developed in 8 patients (1.47%), with the incidence rates being 4.42% in the LLND+ group and 0.69% in the LLND–group, respectively (p=0.012). Three of 8 patients had developed severe postoperative complications, and the other two patients needed intraoperative repair of the iliac vein during LLND procedure. Multivariate analysis identified the incidence of postoperative complications and LLND as the independent risk factors of VTE. Conclusion: Patients undergoing rectal cancer surgery with LLND should be closely monitored for signs of VTE.

7. Clinical and Pathological Analysis of Perianal Paget's Disease: A Case Report and Review of 89 Cases.

Author

Ishii K, Takahashi H, Tsuji H, Ishihara T, Iwami Y, Juavijitjan W, Yokota M, Takaichi S, Paku M, Iwamoto K, Ohashi T, Nakahara Y, Asaoka T, Matsuda C, Nishikawa K, and Omori T

Abstract

Background/aim: Perianal Paget's disease (PPD) is an intraepithelial invasion of the perianal skin that is frequently associated with anorectal carcinoma. Rectal canal carcinoma with Pagetoid spread (PS) is a relatively rare disease, and few reports on its outcomes are available. The relatively rare nature of this disease makes the development of treatment recommendations difficult. This study aimed to clarify the characteristics of the disease and factors related to prognosis. We present a case report and review of 89 cases, including those from the existing literature and our own experience., Case Report: The patient was an 81-year-old man who was referred to our hospital for surgery after endoscopic examination of the lower gastrointestinal tract revealed cancer of the anal canal with PS. Physical examination revealed erythema and erosions around the anus. Lower gastrointestinal endoscopy revealed an erythematous area and a continuous raised lesion in the anal canal. We diagnosed the patient with anal canal carcinoma with PS, and robot-assisted abdominoperineal resection was performed., Conclusion: Our findings indicate that the five-year survival rate for PPD patients was 63%, comparable to that of anal canal cancer without PS. The histological type and presence of lymph node metastasis may be related to the prognosis. The study suggests that early-stage patients with favorable histological types and no lymph node involvement may benefit from less invasive treatment options, such as endoscopic submucosal dissection., Competing Interests: The Authors declare no conflicts of interest in relation to this study., (©2025 The Author(s). Published by the International Institute of Anticancer Research.)

Published
2025
Full Text
View/download PDF

8. Therapeutic targeting of Syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers.

Author

Takeda M, Theardy MS, Sorokin A, Coker O, Kanikarla P, Chen S, Yang Z, Nguyen P, Wei Y, Yao J, Wang X, Yan L, Jin Y, Cai Y, Paku M, Chen Z, Li KZ, Citron F, Tomihara H, Gao S, Deem AK, Zhao J, Wang H, Hanash S, DePinho RA, Maitra A, Draetta GF, Ying H, Kopetz S, and Yao W

Abstract

The therapeutic benefit of recently developed mutant KRAS (mKRAS) inhibitors has been limited by the rapid onset of resistance. Here, we aimed to delineate the mechanisms underlying acquired resistance to mKRAS inhibition and identify actionable targets for overcoming this clinical challenge. Previously, we identified Syndecan-1 (SDC1) as a key effector for pancreatic cancer progression whose surface expression is driven by mKRAS. By leveraging both pancreatic and colorectal cancer models, we found that surface SDC1 expression was initially diminished upon mKRAS inhibition, but recovered in tumor cells that bypass mKRAS dependency. Functional studies showed that these tumors depended on SDC1 for survival, further establishing SDC1 as a driver for the acquired resistance to mKRAS inhibition. Mechanistically, we revealed that the YAP1-SDC1 axis was the major driving force for bypassing mKRAS dependency to sustain nutrient salvage machinery and tumor maintenance. Specifically, YAP1 activation mediated the recovery of SDC1 localization on cell surface that sustained macropinocytosis and enhanced the activation of multiple RTKs, promoting resistance to KRAS-targeted therapy. Overall, our study has provided the rationale for targeting the YAP-SDC1 axis to overcome resistance to mKRAS inhibition, thereby revealing new therapeutic opportunities for improving the clinical outcome of patients with KRAS-mutated cancers.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results